GB0503955D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0503955D0
GB0503955D0 GBGB0503955.7A GB0503955A GB0503955D0 GB 0503955 D0 GB0503955 D0 GB 0503955D0 GB 0503955 A GB0503955 A GB 0503955A GB 0503955 D0 GB0503955 D0 GB 0503955D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0503955.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0503955.7A priority Critical patent/GB0503955D0/en
Publication of GB0503955D0 publication Critical patent/GB0503955D0/en
Priority to PCT/EP2006/001440 priority patent/WO2006089689A1/en
Priority to PE2006000217A priority patent/PE20061229A1/en
Priority to ARP060100661A priority patent/AR052488A1/en
Priority to TW095106174A priority patent/TW200640870A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0503955.7A 2005-02-25 2005-02-25 Novel compounds Ceased GB0503955D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB0503955.7A GB0503955D0 (en) 2005-02-25 2005-02-25 Novel compounds
PCT/EP2006/001440 WO2006089689A1 (en) 2005-02-25 2006-02-15 2-quinolone compounds as inhibitors of phosphodiesterases
PE2006000217A PE20061229A1 (en) 2005-02-25 2006-02-23 2-QUINOLONE DERIVED COMPOUNDS AS PDE4 INHIBITORS
ARP060100661A AR052488A1 (en) 2005-02-25 2006-02-23 DERIVATIVES OF 2-QUINOLONES AS INHIBITORS OF PHOSPHODESTERASES
TW095106174A TW200640870A (en) 2005-02-25 2006-02-23 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0503955.7A GB0503955D0 (en) 2005-02-25 2005-02-25 Novel compounds

Publications (1)

Publication Number Publication Date
GB0503955D0 true GB0503955D0 (en) 2005-04-06

Family

ID=34430239

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0503955.7A Ceased GB0503955D0 (en) 2005-02-25 2005-02-25 Novel compounds

Country Status (5)

Country Link
AR (1) AR052488A1 (en)
GB (1) GB0503955D0 (en)
PE (1) PE20061229A1 (en)
TW (1) TW200640870A (en)
WO (1) WO2006089689A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012513464A (en) * 2008-12-23 2012-06-14 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク Phosphodiesterase inhibitors and uses thereof
US8367829B2 (en) 2010-05-10 2013-02-05 Gilead Sciences, Inc. Bi-functional pyrazolopyridine compounds
EP2569285A1 (en) 2010-05-10 2013-03-20 Gilead Sciences, Inc. Bifunctional quinoline derivatives
CN103508950B (en) * 2012-06-25 2016-04-20 南开大学 Containing 4-hydroxyl-2-quinolinones compound and the Synthesis and applications thereof of imine structure
CA2900302C (en) 2013-02-19 2018-07-03 Pfizer Inc. Azabenzimidazole compounds as inhibitors of pde4 isozymes for the treatment of cns and other disorders
JP6713982B2 (en) 2014-07-24 2020-06-24 ファイザー・インク Pyrazolopyrimidine compounds
JP6506833B2 (en) 2014-08-06 2019-04-24 ファイザー・インク Imidazopyridazine compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0912519A1 (en) * 1996-05-20 1999-05-06 Darwin Discovery Limited Quinoline sulfonamides as tnf inhibitors and as pde-iv inhibitors
TWI328009B (en) * 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors

Also Published As

Publication number Publication date
PE20061229A1 (en) 2006-12-04
TW200640870A (en) 2006-12-01
AR052488A1 (en) 2007-03-21
WO2006089689A1 (en) 2006-08-31

Similar Documents

Publication Publication Date Title
AP2007004171A0 (en) Novel compounds
EP1868612A4 (en) Novel compounds
EP1868611A4 (en) Novel compounds
GB0503955D0 (en) Novel compounds
EP1869026A4 (en) Novel compounds
GB0500140D0 (en) Novel compounds
GB0500923D0 (en) Novel compounds
GB0501961D0 (en) Novel compounds
GB0500284D0 (en) Novel compounds
GB0500285D0 (en) Novel compounds
GB0500405D0 (en) Novel compounds
GB0500406D0 (en) Novel compounds
GB0504099D0 (en) Novel compounds
GB0500839D0 (en) Novel polyacetylen compounds
GB0500883D0 (en) Novel compounds
GB0500884D0 (en) Novel compounds
GB0500885D0 (en) Novel compounds
GB0500886D0 (en) Novel compounds
GB0500887D0 (en) Novel compounds
GB0500916D0 (en) Novel compounds
GB0500919D0 (en) Novel compounds
GB0500920D0 (en) Novel compounds
GB0500921D0 (en) Novel compounds
GB0500925D0 (en) Novel compounds
GB0504098D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)